Balance Sheet	Dec. 31, 2019 USD ($)
ASSETS
Current asset - Other receivable	$ 25
Deferred offering costs	106,870
Total Assets	106,895
Current liabilities
Accrued expenses	1,000
Promissory note - related party	80,808
Total Current Liabilities	81,808
Commitments
Stockholders' Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value; 50,000,000 shares authorized; 6,337,500 shares issued and outstanding(1)	634	[1]
Additional paid-in capital	25,453
Accumulated deficit	(1,000)
Total Stockholders' Equity	25,087
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 106,895

[1] Included up to 787,500 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. As a result of the underwriters' election to fully exercise their over-allotment option on February 10, 2020, the shares were no longer subject to forfeiture (see Note 5 and 7).